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underwent robotic sacrocolpopexy for POP-Q Stage IV VVP. 50 pa-
tients undergoing repair with a heavy mesh weight (52 g/m2, 527 mi-
crons thick, and a suture pull out strength of 18.3 N) were matched to 50
patients undergoing repair with a lighter weight mesh ( 25 g/m2, 200
microns thick, and suture pull out strength of 23.3 N). At two year follow-
up, anatomic success for apical prolapse was 100% and 2 patients (4%)
in each group were found to have residual Grade 2 anterior prolapse
and 2 patients (4%) in each group found to have Grade 2 posterior
prolapse. De novo SUI was found in 5 patients (10%) in the heavy mesh
group and 4 patients (8%) in the lighter mesh group. All de novo SUI
patients did not have a mid urethral sling, MUS, placed at the time of the
procedure. There was one mesh erosion in the light weight mesh group
in a salvage patient that underwent concomitant pre-existing mesh
removal at the time of surgery.
CONCLUSIONS: Although the two Y-meshes are markedly
different in their weight, surface area, thickness and suture pullout
strength, there was no observed significant difference in the anatomic
success of repair, the rate of de novo stress urinary incontinence or
mesh erosion. The rates of de novo SUI seen in this study, have led us
to perform a MUS procedure at the time of sacrocolpopexy for all Grade
IV prolapse patients.
Source of Funding: nonePD17-04
POLYVINYLDENFLUORID (PVDF) VERSUS
POLYPROPYLENE (PP) MESH FOR SACROCOLPOPEXYManuel Di Biase*, Illiano Ester, Elena Sarti, Alessandro Zucchi,
Perugia, Italy; Raffaele Balsamo, Catanzaro, Italy; Antonio Pastore,
Latina, Italy; Elisabetta Costantini, Perugia, Italy
INTRODUCTION AND OBJECTIVES: The aim of this study
was to compare a polymer mesh made of Polyvinyldenfluorid to poly-
propylene, the mesh material most commonly used in pelvic organ
prolapse (POP) surgical repair, in terms of anatomical and functional
results as well as safety, in patients who underwent sacrocolpo-
pexy (SC)
METHODS: This series included women who underwent SC for
stages III or IV POP, according to the POP- Quantification (POP-Q)
system, from 2005 to 2015, using either PP (Cousin Biotech Sac-
romesh) or PVDF (DynaMesh-PRS) mesh. All women were preop-
eratively evaluated with history, physical examination and urodynamics.
Urinary and sexual symptoms were assessed with the Urogenital
Distress Inventory (UDI), the Incontinence Impact Questionnaire (IIQ-7)
and the Female Sexual Function Index (FSFI) questionnaire. At the
follow-up all patients were recalled and re-assessed with physical ex-
amination and the same questionnaires also used at baseline. Patients’
satisfaction was recorded with the VAS score and the Patient Global
ImpressioneImprovement (PGI-I) questionnaire.
RESULTS: Between January and May 2016, 136 patients with
at least 1 year follow-up were re-assessed: 73 who had polypropylene
mesh POP repair (PP group) and 63 who had PVDF mesh repair (PVDF
group). The only significant difference between the two groups was
duration of follow-up: 94.921.7 months for the PP and 29.813.8
months for the PVDF group because the last one was marketed later.
Postoperative anatomical correction rates (success: POP stages 0 or I),
voiding and storage symptoms, urgency and stress incontinence,
questionnaire scores and mesh erosion rates are reported in Table 1.
Most outcomes were not significantly different between the two groups
with the exception of storage symptoms, sexual symptoms and UDI-6
scores that were better in the PVDF group. Subjective patient satis-
faction was high in both groups with no significant differences be-
tween them
CONCLUSIONS: Our results suggest that PVDF is at least as
safe as polypropylene when used in POP repair. PVDF filaments have
an excellent biocompatibility reducing adverse foreign body reactionssuch as granuloma formation, are associated with reduced bacterial
colonization and maintain their tensile strength longer than poly-
propylene, that may explain the better results of PVDF in storage and
sexual symptoms
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INTRODUCTION AND OBJECTIVES: The present randomized
study compares Laparoscopic sacropexy (LSC) and Robotic assisted
sacropexy (RASC) in women with advanced pelvic organ prolapse
(POP) to demonstrate the equivalence between the two techniques
METHODS: Consecutive patients affected by symptomatic
POP stage>II according to the POP-Q classification were prospectively
randomized to test the clinical equivalence of RASC and LS. All women
were preoperatively evaluated with history and physical examination.
Urinary and sexual symptoms were assessed with the Urogenital
Distress Inventory (UDI), the Incontinence Impact Questionnaire (IIQ-7)
and the Female Sexual Function Index (FSFI) questionnaire. As primary
outcome we evaluated the anatomical results considering as failure a
POP>2 stage. Then we evaluated the difference between the two
groups in terms of hospital stay length, blood loss, operating time,
presence of voiding or storage symptoms and sexual function through
the aforementioned questionnaires
RESULTS: To date 21 patients have been randomized to
RASC and 19 to LSC. The mean follow-up was 23,36 months. No
significant inter-group differences emerged in the pre-operative evalu-
ations of age (mean 63.5 vs 58.82 yrs for RASC and LSC, p¼0.06) and
BMI (mean 24.59 vs 25.41 kg/m2 for RASC and LSC, p¼0.55). The
objective success rate was 81% for RASC vs 78,9% for LSC (p¼0.6),
85% for RASC vs 63,2% for LSC (p¼0.8) and 100% for RASC vs 94,7%
for LSC (p¼0.57) for cystocele, rectocele and point c/D repair respec-
tively. Although not significant, operating time was longer for LSC
(mean 213 min for LSC vs 184 min for RASC, p¼0.11) and intra-
operative blood loss was higher in RASC (mean 32 ml for RASC vs
47 ml for LSC, p¼0.46). No difference emerged in hospital stays (mean
3.8 days for LSC vs 3.9 days for RASC, p¼0.8). Functional results are
reported in table 1. No major complications were detected, only 2 grade
III complication according to Clavien-Dindo classification has been re-
ported in the LSC group (1 bladder injury and 1 mesh exposure). The
subjective success rate was very high, 100% of patients of both groups
